Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC

Clinical trial NCT02194556 · UNKNOWN

Trial details

NCT number: NCT02194556
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

EGFR Positive Non-small Cell Lung Cancer Adenocarcinoma

Start date: 2014-07-01
Primary completion: 2017-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.